Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Dušan SredojevićCentre of Excellence for Photoconversion, Vinča Institute of Nuclear Sciences-National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.
Vesna LazićCentre of Excellence for Photoconversion, Vinča Institute of Nuclear Sciences-National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0001-6440-6577
Andrea PirkovićDepartment for Biology of Reproduction, INEP Institute for Application of Nuclear Energy, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-1182-4895
Jovana PerišaCentre of Excellence for Photoconversion, Vinča Institute of Nuclear Sciences-National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.
Natalija MurafaInstitute of Inorganic Chemistry of the Czech Academy of Sciences, 250 68 Husinec-Řež, Czech Republic.
Biljana Spremo-PotparevićDepartment of Pathobiology, Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Serbia.
Lada ŽivkovićDepartment of Pathobiology, Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Serbia.
Dijana TopalovićDepartment of Pathobiology, Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0001-6546-2626
Aleksandra ZarubicaDepartment of Chemistry, Faculty of Science and Mathematics, University of Niš, Višegradska 33, 18000 Niš, Serbia.
Milica Jovanović KrivokućaDepartment for Biology of Reproduction, INEP Institute for Application of Nuclear Energy, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0001-8292-4853
Jovan M NedeljkovićCentre of Excellence for Photoconversion, Vinča Institute of Nuclear Sciences-National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.
Funding
Ministry of Education, Science, and Technological Development of the Republic of Serbia 451-03-1/2022-14/200017Ministry of Education, Science, and Technological Development of the Republic of Serbia 451-03-68/2022-14/200019Ministry of Education, Science, and Technological Development of the Republic of Serbia 451-03-68/2022-14/200161Ministry of Education, Youth and Sports of the Czech Republic LM2018124Texas A&M University at Qatar NPRP11S-1126-170033
6 · The paper itself
Abstract
The antibacterial performance and cytotoxic examination of in situ prepared silver nanoparticles (Ag NPs), on inorganic-organic hybrid nanopowder consisting of zirconium dioxide nanoparticles (ZrO
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Toxicity of Silver Nanoparticles Supported by Surface-Modified Zirconium Dioxide with Dihydroquercetin. · full record | OpenQuestion